Application of penehyclidine hydrochloride in preparing medicament for treating cardiogenic shock
A kind of penehyclidine hydrochloride, cardiogenic shock technology, applied in the field of medicine
Inactive Publication Date: 2009-07-08
CHENGDU LIST PHARMA
View PDF0 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Digoxin not routinely used in shock but may be of value in patients with supraventricular tachycardia
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0191] Penehyclidine Hydrochloride 0.1g
[0192] water 1000ml
[0193] Prepare 1,000 sticks of penehyclidine hydrochloride injection or 50 bottles of spray for treating cardiogenic shock disease.
Embodiment 2
[0195] Penehyclidine Hydrochloride 1g
[0196] water 1000ml
[0197] Prepare 1,000 sticks of penehyclidine hydrochloride injection or 50 bottles of spray for treating cardiogenic shock disease.
Embodiment 3
[0199] Penehyclidine Hydrochloride 5g
[0200] water 1000ml
[0201] Prepare 1,000 sticks of penehyclidine hydrochloride injection or 50 bottles of spray for treating cardiogenic shock disease.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to the use of penehyclidine hydrochloride in the preparation of medicines for treating cardiogenic shock diseases indicating that, in pathological changes, systolic pressure and mean arterial pressure decrease at least by 40%, the maximum rise speed of internal pressure of left ventricle (LV+dp / dtmax) decreases at least 80%, cardiac output decreases at least 40%. The application effect of the invention is shown by the influence of the penehyclidine hydrochloride on acute cardiogenic shock modles.
Description
technical field [0001] The invention belongs to the field of medicines, in particular to the new medical application of penehyclidine hydrochloride, in particular to the application of penehyclidine hydrochloride in the preparation of medicines for treating cardiogenic shock diseases. The pathological changes of the cardiogenic shock are as follows: the systolic blood pressure and the mean arterial pressure drop by at least 40%, the maximum rate of increase in the left ventricular pressure (LV+dp / dt max ) decreased by at least 80%, and cardiac output decreased by at least 40%. Background technique [0002] Penehyclidine hydrochloride, English name Penehyclidine Hydrochloride, chemical name 3-(2-cyclopentyl-2-hydroxy-2-phenylethoxy)quinuclidine hydrochloride, molecular formula C 20 h 29 NO 2 • HCl, molecular weight 351.92. [0003] Penehyclidine hydrochloride is a new type of anticholinergic drug with selective M 1 , M 3 and N 1 , N 2 Receptor antagonism, has a strong...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/439A61P9/00A61K9/08A61K9/20A61K9/48
Inventor 朱登军赵力科杨礼茹
Owner CHENGDU LIST PHARMA